Cipla Swings On Acquisition Plans – Gold Silver Reports

The drugmaker plans to acquire 33 percent stake in Avenue Therapeutics for $35 million at $6 per share, according to its stock exchange notification.

Shares of the pharmaceutical company fluctuated between gains and losses to trade at Rs 528.40.

Avenue Therapeutics shares currently trade at $4.16 in the U.S.

Spread the love

Neal Bhai has been involved in the Bullion and Metals markets since 1998 – he has experience in many areas of the market from researching to trading and has worked in Delhi, India. Mobile No. - 9899900589 and 9582247600

Leave a Comment